Malvern Panalytical Joins IPAC-RS as an Associate Member: Advancing Aerosol Science and Regulatory Standards

Malvern Panalytical is proud to announce it is now an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) – an association that advances the science and regulatory standards of orally inhaled and nasal drug products (OINDPs) through collaboration, research, and development. 

This strategic partnership underpins Malvern Panalytical’s commitment to innovation in aerosol particle analysis and advanced particle characterization, particularly in the rapidly evolving field of OINDPs.

Malvern Panalytical is excited to bring its analytical expertise and powerful combination of market-leading technologies, including the Spraytec for aerosol particle analysis, Morphologi MDRS for advanced particle characterization and chemical analysis, and the Zetasizer and Mastersizer for comprehensive particle size and zeta potential analysis, to the forefront of regulatory science discussions. 

Advancing Regulatory Science Through Collaboration

By participating in IPAC-RS, Malvern Panalytical will collaborate with key industry leaders and regulatory bodies, contributing effectively to the ongoing development of robust regulatory frameworks.

The Malvern Panalytical team will engage in various working groups focused on enhancing product quality and regulatory compliance for OINDPs, including taking part in discussions surrounding innovative applications, sustainability in delivery systems, and critical regulatory challenges. 

Supporting Quality and Innovation in the OINDP Industry

Malvern Panalytical is committed to leveraging its advanced instrumentation and expertise to support the OINDP industry in meeting evolving regulatory expectations. The expert team, led by Tom Ormsbee, Account Manager at Malvern Panalytical, will develop guidelines and best practices that enhance the quality of inhaled and nasal products, thereby positively impacting patient outcomes.

With extensive experience in utilizing its innovative technologies in the dynamic and growing OINDP market, Malvern Panalytical is well-positioned to drive advancements that not only meet regulatory requirements but also exceed the expectations of manufacturers and patients alike.

Shaping the Future of Inhaled Drug Products

As Malvern Panalytical embarks on this new chapter with IPAC-RS, the team is excited about the potential for collaborative projects and knowledge sharing that will drive advancements in aerosol science and regulatory practices.

Malvern Panalytical is committed to playing a pivotal role in shaping the future of inhaled drug products and ensuring that its solutions continue to lead the way in quality and innovation.